Jupiter Life Line Hospitals: BUY rating and 340 rupee target from Choice Institutional Equities

what happened

Analysts at Choice Institutional Equities kept their BUY rating on shares of Indian hospital operator Jupiter Life Line Hospitals (JLHL), but lowered the target price to 340 rupees from 410. The brokerage's report was published by TradingView.

The analysts expect steady growth, driven by a faster ramp-up at Dombivli, higher utilisation of established hospitals and a gradual shift toward super specialities. Planned expansion in Pune South, Mira-Bhayandar and BKC adds capacity, while operating leverage and a maturing case mix could lift profitability over the medium term.

The forecast projects revenue, EBITDA and APAT growing at compound annual rates of 23.4%, 23.1% and 20.1% over FY26–29E. The target is based on a DCF valuation that includes the BKC expansion plan. The cut to the profit forecast reflects higher debt levels needed to fund the company's expansion.

why it matters

For investors, the key issue is the balance sheet: higher borrowing to fund the network expansion could weigh on net profit even as operating performance improves. That assessment of financing risk explains the lower target while the brokerage keeps a positive view of the business.

tags

instruments